PACK IN HAND · ONE-PAGE CHECK
Medicine pack check sheet
Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.
Entries stay only in this open page and are not saved or sent.
Published record starting point
- Record display name
- Invokana
- Generic name / active ingredient
- canagliflozin
- Dosage-form class
- INVOKANA canagliflozin film-coated oral tablets: 100 mg and 300 mg. Current-label text identities are retained for 30-count bottles, while exact current official display panels are retained for 90-count bottles. See the primary label for 500-count and other packages.
- Route
- Route documented in the linked source label
- Record reviewed
- 2026-08-28
Copy from the pack in hand
Source-linked reading points
- 100 mg and 300 mg are different tablet strengths. Colour, imprint and bottle count only help compare the cited U.S. label. They do not mean a person can split, combine, double, halve or substitute another canagliflozin or glucose-lowering product by milligrams.
- Label terms such as diabetes, cardiovascular and kidney do not enable a webpage to decide personal suitability. Kidney function, volume status, age, the complete medicine list, history and the current prescription need professional review together.
- INVOKAMET, INVOKAMET XR and another metformin-containing combination cannot be treated as the same medicine because of a name or shared ingredient. Any actual co-use question involving insulin, an insulin secretagogue, a diuretic or another glucose-lowering medicine requires review of the complete medicine list by a pharmacist or prescribing team.
- Adverse-reaction and warning material in a label is safety information to read and review, not a webpage rule that decides continuation, pausing, switching or self-management for anyone. With an acute or serious concern, use timely local medical or emergency support.
Reviewed presentation examples — compare every field
- Canagliflozin 100 mg per tablet; 30-tablet bottleNDC 50458-140-30
- Canagliflozin 300 mg per tablet; 30-tablet bottleNDC 50458-141-30
- Canagliflozin 100 mg per tablet; 90-tablet bottle (NDC 50458-140-90)NDC 50458-140-90
- Canagliflozin 300 mg per tablet; 90-tablet bottle (NDC 50458-141-90)NDC 50458-141-90